Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.04−0.05 (-4.59%)
Close on Nov 17, 2026Market cap $9.37MP/E –Yield –
Lisata Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Lisata Therapeutics's pe ratio was 1.5× on Feb 28, 2019.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2019 | Feb 28, 2019 | 1.5× | +0.1 |
| 2018 | Dec 31, 2018 | 1.4× | – |
See a number that looks wrong?